Louis Ignarro is a renowned Pharmacologist who has a net worth of $1.9 billion. Born in 1941, he is best known for his research in the field of pharmacology, which earned him the 1998 Nobel Prize in Physiology or Medicine. In 1985, he joined the faculty of the University of California, Los Angeles' School of Medicine, where he has continued to make significant contributions to the field.
Louis Ignarro is a member of Pharmacologist
Age, Biography and Wiki
💰 Net worth: $1.9 billion (2024)
Louis Ignarro, the renowned pharmacologist hailing from New York, has amassed an impressive net worth of approximately $1.9 billion as of 2024. Ignarro's expertise in the field of pharmacology, particularly his groundbreaking research on the cardiovascular system, has earned him widespread recognition and financial success. With numerous patents and academic contributions to his name, Ignarro's work has revolutionized the medical world, particularly in the area of nitric oxide research. Ignarro's immense net worth is a testament to both his groundbreaking scientific achievements and his significant entrepreneurial endeavors.
About
Known for his research in the field of pharmacology, he received the 1998 Nobel Prize in Physiology or Medicine for his work on nitric oxide. In 1985, he joined the faculty of the University of California, Los Angeles' School of Medicine.
Before Fame
He earned his Bachelor of Science and Doctor of Philosophy degrees in pharmacology from, respectively, Columbia University and the University of Minnesota.
Trivia
He taught for over a decade at Tulane University's medical school and founded an organization called the Nitric Oxide Society.
Family Life
He was raised in New York City by Italian immigrant parents. He and his wife later settled in Southern California.
Associated With
He and Gertrude B. Elion were both recipients of the Nobel Prize in Physiology or Medicine; Elion received the honor in 1988, and Ignarro shared the 1998 prize with biochemist Robert F. Furchgott and fellow pharmacologist Ferid Murad.
